Gene that drives blood cancer drug resistance uncovered with new CRISPR activation tool

Researchers have uncovered a previously unknown gene that causes resistance to a leading blood cancer drug, as well as several genes that accelerate lymphoma growth, using a powerful new CRISPR activation library.

≈